OPIRANZA
Live / Allowed — Notice of allowance issued (as of 13 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Apr 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97883560
- Mark type
- Stylized text
- Filed
- 11 Apr 2023
- Published for opposition
- 18 Nov 2025
- Attorney of record
- Lisa M. Melanson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the management of opioid addiction; opioid agonist pharmaceutical preparations
Owner
- FP Pharma Inc., Vancouver, BC, CA
- FP Pharma Inc., Vancouver, BC, CA
Prosecution history
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Sept 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 25 Sept 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 25 Sept 2025 — INQUIRY TO SUSPENSION E-MAILED
- 25 Sept 2025 — SUSPENSION INQUIRY WRITTEN
- 21 Aug 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 20 Feb 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 20 Feb 2025 — LETTER OF SUSPENSION E-MAILED
- 20 Feb 2025 — SUSPENSION LETTER WRITTEN